Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer.

Our longitudinal study comprehensively revealed the clinical characteristics and survival of patients with the original TNBC subtypes and validated the consistency of most molecular subtypes throughout disease progression. However, we emphasize the major importance of repeat pathologic confirmation of the MES subtype.